- Home
- PUBM vs ZVRA Comparison
PUBM vs ZVRA Comparison
Compare PUBM & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PUBM
- ZVRA
- Stock Information
- Founded
- PUBM 2006
- ZVRA 2006
- Country
- PUBM United States
- ZVRA United States
- Employees
- PUBM N/A
- ZVRA N/A
- Industry
- PUBM Computer Software: Prepackaged Software
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- PUBM Technology
- ZVRA Health Care
- Exchange
- PUBM Nasdaq
- ZVRA Nasdaq
- Market Cap
- PUBM 576.6M
- ZVRA 481.7M
- IPO Year
- PUBM 2020
- ZVRA 2015
- Fundamental
- Price
- PUBM $11.12
- ZVRA $11.11
- Analyst Decision
- PUBM Buy
- ZVRA Strong Buy
- Analyst Count
- PUBM 11
- ZVRA 9
- Target Price
- PUBM $22.60
- ZVRA $23.25
- AVG Volume (30 Days)
- PUBM 532.6K
- ZVRA 1.4M
- Earning Date
- PUBM 08-11-2025
- ZVRA 08-12-2025
- Dividend Yield
- PUBM N/A
- ZVRA N/A
- EPS Growth
- PUBM N/A
- ZVRA N/A
- EPS
- PUBM 0.10
- ZVRA N/A
- Revenue
- PUBM $288,380,000.00
- ZVRA $40,588,000.00
- Revenue This Year
- PUBM $2.80
- ZVRA $303.00
- Revenue Next Year
- PUBM $10.43
- ZVRA $77.66
- P/E Ratio
- PUBM $112.60
- ZVRA N/A
- Revenue Growth
- PUBM 3.62
- ZVRA 46.47
- 52 Week Low
- PUBM $7.46
- ZVRA $6.10
- 52 Week High
- PUBM $22.25
- ZVRA $13.16
- Technical
- Relative Strength Index (RSI)
- PUBM 37.27
- ZVRA 52.33
- Support Level
- PUBM $11.94
- ZVRA $10.69
- Resistance Level
- PUBM $12.84
- ZVRA $11.95
- Average True Range (ATR)
- PUBM 0.49
- ZVRA 0.51
- MACD
- PUBM -0.19
- ZVRA -0.21
- Stochastic Oscillator
- PUBM 0.00
- ZVRA 17.00
About PUBM PubMatic Inc.
PubMatic Inc is a supply-side platform provider in the digital advertising technology market. These platforms help publishers, which supply digital ad inventory, manage their inventory, selling a high percentage of their inventory (increase the ad fill rate) and maximizing revenue per ad sold (optimize yield). The company generates revenue mainly by taking a piece of the ad sales that it enables. Buyers on the platform include intermediary buyers, such as demand-side platforms, or advertisers and ad agencies directly. Geographically, the company generates the majority of its revenue from the United States, followed by EMEA and APAC.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.